1 of 1
Story summary
- Eric Dane advocates for the Accelerating Access to Critical Therapies for ALS Act, which expires in 2026.
- The Act, passed in 2021, provides five years of funding and early treatment access.
- Dane met with U.S. Rep. Eric Swalwell to press for research funding and early access.
- He notes diagnosis delays hinder trial participation and vows to fight for his life.
